Related Experiment Video
Updated: Mar 20, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy
Alison Kent1, Shamez N Ladhani2, Nick J Andrews3
1Paediatric Infectious Diseases Research Group and Vaccine Institute, St George's, University of London, London, United Kingdom; alisonkent@doctors.org.uk.
Insights
Maternal antenatal pertussis vaccination in early pregnancy boosts antibody levels in premature infants. This protection may wane after infant immunization but appears to offer initial benefits for vulnerable newborns.
Area of Science:
- Immunology
- Neonatal Care
- Vaccinology
Background:
- Maternal antenatal pertussis vaccination is recommended for neonatal pertussis prevention.
- Its efficacy in protecting premature infants remains largely unknown.
- This study investigated antibody responses in premature infants born to vaccinated mothers.
Purpose of the Study:
- To determine if maternal antenatal pertussis vaccination enhances antibody concentrations in premature infants.
- To compare antibody levels in premature infants of vaccinated versus unvaccinated mothers.
Main Methods:
- Mothers received a combined tetanus, diphtheria, acellular pertussis, and inactivated polio vaccine.
- Antibody concentrations (pertussis toxin, FHA, fimbriae) were measured in premature infants at 2, 5, and 12 months of age.
- Infants were part of a randomized controlled trial for pneumococcal conjugate vaccine schedules.
Main Results:
- Premature infants of vaccinated mothers had significantly higher antibody concentrations at 2 months for all measured pertussis antigens.
- Earlier maternal vaccination correlated positively with higher immunoglobulin G concentrations at 2 months.
- Infants of vaccinated mothers showed lower FHA antibody levels after primary immunization, which resolved by 12 months.
Conclusions:
- Maternal vaccination in early third trimester may confer protection to premature infants.
- Antenatal pertussis vaccination appears beneficial for premature infants' early antibody levels.
Background And Objectives:
Maternal antenatal pertussis-containing vaccination is recommended for the prevention of neonatal pertussis, but the ability of maternal vaccination to protect premature infants is unknown. We hypothesized that that infants born prematurely to antenatally vaccinated women would have higher pertussis antibody concentrations than those born to unvaccinated women.
Methods:
Mothers had been offered a combined tetanus, diphtheria, 5-component acellular pertussis, inactivated polio vaccine from 28 weeks' gestation as part of their routine antenatal care. Premature infants of vaccinated and unvaccinated mothers enrolled in a randomized controlled trial of pneumococcal conjugate vaccine schedules had antibody concentrations (pertussis toxin, filamentous hemoagglutinin [FHA], and fimbriae 2 and 3) measured at 2 months (before primary vaccination), 5 months (1 month after primary vaccination), and 12 months of age.
Results:
Mothers of 31 (19%) of 160 premature infants had received combined tetanus, diphtheria, 5-component acellular pertussis, inactivated polio vaccine in pregnancy. Compared with infants of unvaccinated mothers, those born to vaccinated mothers had significantly higher antibody concentrations at 2 months for all measured vaccine antigens (P < .001). The number of days between maternal vaccination and delivery and immunoglobulin G concentration at 2 months of age was positively correlated for pertussis toxin (P = .011) and FHA (P = .001). After primary immunization, infants of vaccinated mothers had significantly lower antibody concentrations for FHA (P = .003) compared with infants of unvaccinated mothers; these differences had resolved by 12 months of age.
Conclusions:
Maternal vaccination administered early in the third trimester may provide protection for infants born prematurely.
More Related Videos
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccinations
Diphtheria
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of the Oral Microbiota